Your browser doesn't support javascript.
loading
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
Gleeson, M; Kentwell, M; Meiser, B; Do, J; Nevin, S; Taylor, N; Barlow-Stewart, K; Kirk, J; James, P; Scott, C L; Williams, R; Gamet, K; Burke, J; Murphy, M; Antill, Y C; Pearn, A; Pachter, N; Ebzery, C; Poplawski, N; Friedlander, M; Tucker, K M.
  • Gleeson M; Hunter Family Cancer Service, Newcastle, Australia. Electronic address: Margaret.gleeson@health.nsw.gov.au.
  • Kentwell M; Parkville Familial Cancer Clinic, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; The Royal Women's Hospital, Oncology and Dysplasia, Melbourne, Australia.
  • Meiser B; Prince of Wales Clinical School, UNSW Sydney, Australia.
  • Do J; Prince of Wales Clinical School, UNSW Sydney, Australia.
  • Nevin S; Prince of Wales Clinical School, UNSW Sydney, Australia.
  • Taylor N; The Cancer Council New South Wales, Sydney and Faculty of Health Science, University of Sydney, Australia.
  • Barlow-Stewart K; Sydney Medical School, University of Sydney, Australia.
  • Kirk J; Familial Cancer Service, Westmead Hospital, Sydney Medical School, University of Sydney and Centre for Cancer Research, The Westmead Institute for Medical Research, Australia.
  • James P; Parkville Familial Cancer Clinic, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
  • Scott CL; Parkville Familial Cancer Clinic, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; Department of Obstetrics and Gynaecology and Department of Medical Biology, University of Melbourne, Australia.
  • Williams R; Prince of Wales Clinical School, UNSW Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Sydney, Australia.
  • Gamet K; Genetic Health Service NZ Northern Hub, Auckland City Hospital, Auckland, New Zealand.
  • Burke J; Tasmanian Clinical Genetics Service, Royal Hobart Hospital, Hobart, Australia.
  • Murphy M; Parkville Familial Cancer Clinic, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; Bendigo Health Cancer Centre, Bendigo, Australia.
  • Antill YC; Parkville Familial Cancer Clinic, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia; Familial Cancer Centre, Monash Health, Victoria, Australia.
  • Pearn A; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia.
  • Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital, Perth, Australia; School of Medicine, University of Western Australia, Perth, Australia.
  • Ebzery C; Genetic Health Queensland, Royal Brisbane and Women's Hospital, Queensland, Australia.
  • Poplawski N; Adult Genetics Unit, Royal Adelaide Hospital, Adelaide and School of Medicine, University of Adelaide, Australia.
  • Friedlander M; Dept Medical Oncology, Prince of Wales Hospital, Sydney, Australia.
  • Tucker KM; Prince of Wales Clinical School, UNSW Sydney, Australia; Hereditary Cancer Centre, Prince of Wales Hospital, Sydney, Australia.
Gynecol Oncol ; 158(2): 431-439, 2020 08.
Article en En | MEDLINE | ID: mdl-32451123

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Pruebas Genéticas / Carcinoma Epitelial de Ovario / Genética / Oncología Médica Tipo de estudio: Evaluation_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Pruebas Genéticas / Carcinoma Epitelial de Ovario / Genética / Oncología Médica Tipo de estudio: Evaluation_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article